Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma
| Autor: | Van Hal, Nicole L.W., Van Dongen, Guus A.M.S., Ten Brink, Corlinda B.M., Heider, Karl Heinz, Rech-Weichselbraun, Irene, Snow, Gordon B., Brakenhoff, Ruud H. |
|---|---|
| Přispěvatelé: | Radiology and nuclear medicine, Amsterdam Neuroscience - Brain Imaging, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, AII - Inflammatory diseases, Otolaryngology / Head & Neck Surgery, AII - Cancer immunology |
| Jazyk: | angličtina |
| Rok vydání: | 1999 |
| Předmět: | |
| Zdroj: | Van Hal, N L W, Van Dongen, G A M S, Ten Brink, C B M, Heider, K H, Rech-Weichselbraun, I, Snow, G B & Brakenhoff, R H 1999, ' Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma ', Clinical Cancer Research, vol. 5, no. 11, pp. 3534-3541 . Clinical Cancer Research, 5(11), 3534-3541. American Association for Cancer Research Inc. |
| ISSN: | 1078-0432 |
| Popis: | In recent years, the measurement of soluble CD44 levels in the circulation of patients with malignant diseases has been introduced as a new and simple diagnostic tool for the detection of human cancer. The high CD44v6 expression in head and neck squamous cell carcinoma (HNSCC) would enable the use of soluble CD44v6 proteins present in the circulation of HNSCC patients as a marker of disease. In the present study, we determined CD44v6 plasma levels using a domain-specific ELISA in healthy volunteers, non-cancer patients, and HNSCC patients before and after surgical removal of the tumor. A difference between the CD44v6 plasma levels of HNSCC patients and controls could not be observed. Moreover, surgical removal of the tumor did not result in a reduction of the CD44v6 plasma level in the HNSCC patients. In addition, the spectrum of soluble v6-containing CD44 proteins present in the plasma of HNSCC patients and controls was determined by immunoprecipitation experiments, but again, tumor-related isoforms could not he distinguished in patient samples. Additional experiments to unravel the biological source of these circulating proteins indicated surprisingly that the v6-containing proteins present in the circulation of healthy individuals are only released in part, if at all, by activated lymphocytes or other nucleated blood cells. Most circulating CD44v6 proteins seem to be derived from the normal epithelial cell compartments, including breast cells, colon cells, and squamous cells. Taken together, these data do not support the use of soluble CD44v6 as a tumor marker in HNSCC or any other tumor type that has developed from tissues producing soluble isoforms. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|